Family · Pharmaceutical analytical standards
Regadenoson
A selective adenosine A2A receptor agonist that dilates the coronary arteries: approved in the United States in 2008, it is used as a pharmacological stress agent in myocardial perfusion imaging for people who cannot exercise adequately. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It is a derivative of adenosine carrying an extra pyrazole ring: compared with the natural molecule, whose half-life is about ten seconds, it has a biological half-life of 2-3 minutes.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
